Performance analysis of Biocryst Pharmaceuticals (BCRX)
Annual Return
Over the past 3 years, BCRX has had an average annual return of -0.04%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, BCRX has had an average annual return of -12.61%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, BCRX has had an average annual return of +8.77%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Nov 1, 1999, BCRX has had an average annual return of -3.90%, underperforming the benchmark SPY, which returned +8.59% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +6.92% | +3.73% | +25.52% | -47.82% | -17.12% | +85.92% | +115.86% | -57.24% | +64.37% | -22.44% | -38.65% | -15.14% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| +59.99% | +434.97% | -42.47% | -52.23% | -19.99% | +371.45% | -77.83% | -46.54% | -30.98% | +189.83% | -15.63% | +613.50% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -75.76% | -40.22% | -77.55% | +22.92% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -15.63% | +32.97% | +8.80% | -3.78% | -2.72% | -6.41% | +6.92% | ||||||
| 2025 | +5.08% | +8.96% | -12.88% | +17.98% | +21.48% | -16.66% | -9.13% | +2.09% | -8.69% | -3.54% | -1.90% | +8.62% | +3.73% |
| 2024 | -11.54% | +6.25% | -9.76% | -18.71% | +56.42% | -4.35% | +17.79% | +19.39% | -12.54% | +5.40% | -6.38% | +0.26% | +25.52% |
| 2023 | -8.09% | -16.13% | -5.75% | -8.75% | +8.67% | -14.89% | +4.98% | -3.77% | -0.44% | -22.44% | +7.08% | +1.88% | -47.82% |
| 2022 | +11.54% | +7.52% | -2.11% | -42.86% | +0.21% | +13.64% | +4.17% | +26.13% | -9.36% | +5.96% | +0.07% | -14.08% | -17.12% |
| 2021 | +14.37% | +26.54% | -5.65% | +14.39% | +35.54% | +0.26% | +1.96% | -1.25% | -9.72% | +3.89% | -19.23% | +14.85% | +85.92% |
| 2020 | -17.39% | +5.22% | -33.36% | +95.56% | +14.98% | +5.87% | -14.47% | +1.95% | -17.24% | +11.25% | +33.73% | +45.80% | +115.86% |
| 2019 | +7.55% | -4.84% | -1.45% | -8.73% | -52.91% | +8.30% | -16.34% | -5.68% | -4.17% | -30.23% | +42.62% | +21.04% | -57.24% |
| 2018 | -8.36% | +10.45% | -4.06% | +3.17% | +30.68% | -10.86% | +2.93% | +21.36% | +6.57% | -4.06% | +25.41% | -12.08% | +64.37% |
| 2017 | -0.49% | -0.95% | +34.62% | -24.51% | -18.77% | +7.97% | -8.11% | -0.19% | +2.73% | -14.11% | +12.91% | -3.35% | -22.44% |
Drawdown analysis of Biocryst Pharmaceuticals (BCRX)
The maximum drawdown for the BCRX was -97.73%, occurring on Jul 3, 2002. This drawdown has not yet recovered.
The current BCRX drawdown is -74.83%.
Since Nov 1, 1999 BCRX has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 5 times
- 10% or more: 5 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.73% | Aug 25, 2000 | 462 | Jul 3, 2002 | Ongoing | Ongoing | Ongoing |
| -50.76% | Mar 8, 2000 | 28 | Apr 17, 2000 | 91 | Aug 25, 2000 | 119 |
| -29.52% | Jan 19, 2000 | 8 | Jan 31, 2000 | 23 | Mar 3, 2000 | 31 |
| -26.68% | Dec 31, 1999 | 5 | Jan 7, 2000 | 7 | Jan 19, 2000 | 12 |
| -23.36% | Nov 3, 1999 | 23 | Dec 7, 1999 | 13 | Dec 27, 1999 | 36 |
| -6.48% | Mar 3, 2000 | 2 | Mar 7, 2000 | 1 | Mar 8, 2000 | 3 |
| -0.86% | Dec 28, 1999 | 2 | Dec 30, 1999 | 1 | Dec 31, 1999 | 3 |